
Publikationen von Marta Labeur
Alle Typen
Zeitschriftenartikel (28)
1.
Zeitschriftenartikel
11 (7), S. eadn8631 - eadn8631 (2025)
Chronic exposure to glucocorticoids amplifies inhibitory neuron cell fate during human neurodevelopment in organoids. Science advances 2.
Zeitschriftenartikel
112 (9), S. 1426 - 1443.e11 (2024)
Human cortical neurogenesis is altered via glucocorticoid-mediated regulation of ZBTB16 expression. NEURON 3.
Zeitschriftenartikel
110 (1), S. 146 - 160 (2023)
Bi-allelic variants in NAE1 cause intellectual disability, ischiopubic hypoplasia, stress-mediated lymphopenia and neurodegeneration. AMERICAN JOURNAL OF HUMAN GENETICS 4.
Zeitschriftenartikel
120 (49), e2305773120 (2023)
High- throughput screening of glucocorticoid- induced enhancer activity reveals mechanisms of stress- related psychiatric disorders. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 5.
Zeitschriftenartikel
54 (1), S. 51 - 63 (2015)
TMEFF2 is an endogenous inhibitor of the CRH signal transduction pathway. JOURNAL OF MOLECULAR ENDOCRINOLOGY 6.
Zeitschriftenartikel
94 (2), S. 124 - 136 (2011)
Effect of SOM230 (Pasireotide) on Corticotropic Cells: Action in Dogs with Cushing's Disease. Neuroendocrinology 7.
Zeitschriftenartikel
326 (1-2), S. 85 - 88 (2010)
Pituitary tumors: Cell type-specific roles for BMP-4. Molecular and Cellular Endocrinology 8.
Zeitschriftenartikel
70 (5), S. 457 - 462 (2010)
Molecular mechanisms of glucocorticoid receptor signalling. Medicina (Buenos Aires) 9.
Zeitschriftenartikel
117 (10), S. 656 - 656 (2009)
NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Experimental and Clinical Endocrinology & Diabetes 10.
Zeitschriftenartikel
117 (10), S. 656 - 656 (2009)
Activation of NOD and TLR4 innate immune receptors in tumoral pituitary cells and their effects on downstream targets. Experimental and Clinical Endocrinology & Diabetes 11.
Zeitschriftenartikel
203 (1), S. 111 - 122 (2009)
NOD2 receptors in adenopituitary folliculostellate cells: expression and function. Journal of Endocrinology 12.
Zeitschriftenartikel
10 (2 Sp. Iss. SI), S. 103 - 109 (2009)
Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas. Reviews in Endocrine & Metabolic Disorders 13.
Zeitschriftenartikel
71 (Suppl. 2), S. 88 - 94 (2009)
Differential Gene Expression in Models of Pituitary Prolactin-Producing Tumoral Cells. Hormone Research 14.
Zeitschriftenartikel
72 (5), S. 266 - 274 (2009)
Regulation of Pituitary Function by Cytokines. Hormone Research 15.
Zeitschriftenartikel
199 (2), S. 177 - 189 (2008)
Interferon-gamma inhibits cellular proliferation and ACTH production in corticotroph tumor cells through a novel janus kinases-signal transducer and activator of transcription 1/nuclear factor-kappa B inhibitory signaling pathway. Journal of Endocrinology 16.
Zeitschriftenartikel
115 (8), S. 548 - 549 (2007)
Expression and functionality of NOD molecules in the adenopituitary folliculostellate cells. Experimental and Clinical Endocrinology & Diabetes 17.
Zeitschriftenartikel
115 (8), S. 542 - 543 (2007)
Interferon-gamma inhibits cellular proliferation and ACTH production in corticotroph tumor cells through a novel JAK-STAT1/NF-kappa B inhibitory signalling pathway. Experimental and Clinical Endocrinology & Diabetes 18.
Zeitschriftenartikel
115 (8), S. 550 - 550 (2007)
The NAD-dependent protein deacetylase sirt1 regulates POMC transcription and ACTH synthesis. Experimental and Clinical Endocrinology & Diabetes 19.
Zeitschriftenartikel
115 (8), S. 553 - 553 (2007)
Involvement of the calcium-binding protein secretagogin in pituitary adenoma hormone production. Experimental and Clinical Endocrinology & Diabetes 20.
Zeitschriftenartikel
115 (Suppl. 1), S. S86 - S86 (2007)
Bacterial muramy dipeptide differently affect IL-6 and VEGF production in pituitary folliculostellate TtT/GF cells through NOD1 and NOD2 receptors. Experimental and Clinical Endocrinology & Diabetes